Get the Stockscreener App
11.09
1.37%
0.15
Greenwich Lifesciences Inc stock is traded at $11.09, with a volume of 45,636.
It is up +1.37% in the last 24 hours and up +22.54% over the past month.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
See More
Previous Close:
$10.94
Open:
$10.9
24h Volume:
45,636
Relative Volume:
0.90
Market Cap:
$148.25M
Revenue:
-
Net Income/Loss:
$-8.89M
P/E Ratio:
-15.84
EPS:
-0.7
Net Cash Flow:
$-6.48M
1W Performance:
-4.15%
1M Performance:
+22.54%
6M Performance:
-14.30%
1Y Performance:
-28.41%
1-Day Range:
$10.70
$11.29
1-Week Range:
$10.70
$11.73
52-Week Range:
$8.06
$16.50
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Name
Greenwich Lifesciences Inc
Sector
Industry
Phone
203-434-3290
Address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Compare GLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
11.09 | 146.25M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-01-21 | Initiated | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Stock (GLSI) Latest News
Why is Greenwich LifeSciences Inc. stock attracting strong analyst attentionRetirement Planning Tips With Low Risk - jammulinksnews.com
What makes Greenwich LifeSciences Inc. stock price move sharplyFinancial News Opportunities That Work - jammulinksnews.com
Will Greenwich LifeSciences Inc. Stock Benefit from AI and Green Energy TrendsCapital Growth Summary Over Five Years - Newser
What institutional investors are buying Greenwich LifeSciences Inc. stockLow Risk Forecasts For Smart Trading - jammulinksnews.com
Greenwich LifeSciences Inc. stock prediction for this weekPredictive AI Signals for Short-Term Trading - Newser
Forecasting Greenwich LifeSciences Inc. price range with options dataFree Fast Return Equity Trade Forecast - Newser
Using data models to predict Greenwich LifeSciences Inc. stock movementBuy/Sell Zone Confirmation Technical Analysis - Newser
Applying Wyckoff theory to Greenwich LifeSciences Inc. stockFree Alert Feed for Momentum Based Picks - Newser
How does Greenwich LifeSciences Inc. compare to its industry peersDaily Trading Forecasts From AI Tools - jammulinksnews.com
Is Greenwich LifeSciences Inc. stock overvalued or undervaluedInvest confidently with professional market insights - jammulinksnews.com
What is Greenwich LifeSciences Inc. company’s growth strategyPre Market Review For Consistent Profits - jammulinksnews.com
What are the latest earnings results for Greenwich LifeSciences Inc.Get real-time updates on market movers - jammulinksnews.com
What catalysts could drive Greenwich LifeSciences Inc. stock higher in 2025Capitalize on emerging investment opportunities - jammulinksnews.com
What is the dividend policy of Greenwich LifeSciences Inc. stockMaximize gains with data-driven stock picks - jammulinksnews.com
Published on: 2025-07-27 19:29:57 - jammulinksnews.com
What are analysts’ price targets for Greenwich LifeSciences Inc. in the next 12 monthsBuild capital through low-risk investments - jammulinksnews.com
Greenwich LifeSciences Inc. Earnings Report Breakdown: What Investors Should KnowMarket Timing Advice - Newser
How does Greenwich LifeSciences Inc. generate profit in a changing economyGet professional advice for market timing - jammulinksnews.com
How Greenwich LifeSciences Inc. stock performs during market volatilityHigh Accuracy Alerts - Newser
Greenwich LifeSciences Inc. Stock Analysis and ForecastFree Stock Movement Tracking - PrintWeekIndia
What analysts say about Greenwich LifeSciences Inc. stockBreakthrough financial growth - jammulinksnews.com
What drives Greenwich LifeSciences Inc. stock priceAccelerated earnings growth - jammulinksnews.com
Published on: 2025-07-23 01:24:01 - jammulinksnews.com
Is Greenwich LifeSciences Inc. a good long term investmentFree Stock Market Beginners Guide - PrintWeekIndia
Bullish Pattern Emerging on Symphony Limited (SYMPHONY)Phenomenal wealth increase - Jammu Links News
Is GRWG a good long term investmentFree Investment Risk Control - Jammu Links News
Greenwich LifeSciences (NASDAQ:GLSI) Shares Down 5.8% – Should You Sell? - Defense World
Best Stocks for Value Growth Free Stock Club AccessTriple-digit returns - Jammu Links News
Greenwich Lifesciences Inc Stock (GLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):